Search in:

Advanced search

The Journal of Maternal-Fetal & Neonatal Medicine Volume 33, 2020 - Issue 7

Submit an article Journal homepage

156

Views

CrossRef citations to date

Altmetric

Original Articles

Inhibitors of osteoblastogenesis in early human milk and maternal serum: evidence for protective properties of mother’s milk on bone

Despina D. BrianaMedical School, National and Kapodistrian University of Athens, Athens, Greece; Correspondence[email protected] [email protected]

Stavroula GavriliNeonatal Intensive Care Unit, General District Hospital "Alexandra", Athens, Greece;

Sophia GeorgantziNeonatal Intensive Care Unit, General District Hospital "Alexandra", Athens, Greece;

Antonios MarmarinosLaboratory of Clinical Biochemistry – Molecular Diagnostics, 2nd Department of Pediatrics, National and Kapodistrian University of Athens, Athens, Greece;

Konstantinos VoulgarisHellenic Statistical Authority, Athens, Greece

Christos ChristouHellenic Statistical Authority, Athens, Greece

Dimitrios GourgiotisLaboratory of Clinical Biochemistry – Molecular Diagnostics, 2nd Department of Pediatrics, National and Kapodistrian University of Athens, Athens, Greece;

Ariadne Malamitsi-PuchnerMedical School, National and Kapodistrian University of Athens, Athens, Greece;

show all

Pages 1095-1099 | Received 13 Jun 2018, Accepted 17 Aug 2018, Published online: 10 Sep 2018

Cite this article
https://doi.org/10.1080/14767058.2018.1514383
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Reprints & Permissions

References

Javaid MK, Cooper C. Prenatal and childhood influences on osteoporosis. Best Pract Res Clin Endocrinol Metab. 2002;16:349–367.
PubMed Web of Science ®Google Scholar
Vidal K, van den Broek P, Lorget F, et al. Osteoprotegerin in human milk: a potential role in the regulation of bone metabolism and immune development. Pediatr Res. 2004;55:1001–1008.
PubMed Web of Science ®Google Scholar
Fewtrell M. Early nutritional predictors of long-term bone health in preterm infants. Curr Opin Clin Nutr Metab Care. 2011;14:297–301.
PubMed Web of Science ®Google Scholar
Kovacs CS. Calcium and bone metabolism disorders during pregnancy and lactation. Endocrinol Metab Clin North Am. 2011;40:795–826.
PubMed Web of Science ®Google Scholar
Miller JR. The Wnts. Genome Biol. 2002;3:REVIEWS3001–REV11806834.
PubMedGoogle Scholar
Krishnan V, Bryant HU, Macdougald OA. Regulation of bone mass by Wnt signaling. J Clin Invest. 2006;116:1202–1209.
PubMed Web of Science ®Google Scholar
Qiang YW, Barlogie B, Rudikoff S, et al. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma. Bone. 2008;42:669–680.
PubMed Web of Science ®Google Scholar
Chapurlat RD, Confavreux CB. Novel biological markers of bone: from bone metabolism to bone physiology. Rheumatology. 2016;55:1714–1725.
PubMed Web of Science ®Google Scholar
Mao B, Wu W, Davidson G, et al. Kremen proteins are Dickkopf receptors that regulate Wnt/beta-catenin signalling. Nature. 2002;417:664–667.
PubMed Web of Science ®Google Scholar
Fujita K, Janz S. Attenuation of WNT signaling by DKK-1 and -2 regulates BMP2-induced osteoblast differentiation and expression of OPG, RANKL and M-CSF. Mol Cancer. 2007;6:71.
PubMed Web of Science ®Google Scholar
Krause C, Korchynskyi O, de Rooij KD, et al. Distinct modes of inhibition by sclerostin on bone morphogenetic protein and Wnt signaling pathways. J Biol Chem. 2010;285:41614–41626.
PubMed Web of Science ®Google Scholar
ten Dijke PT, Krause C, de Gorter DJ, et al. Osteocyte-derived sclerostin inhibits bone formation: its role in bone morphogenetic protein and Wnt signaling. J Bone Joint Surg Am. 2008;90:31–35.
PubMed Web of Science ®Google Scholar
Silverman SL. Sclerostin. J Osteoporos. 2010;2010:1.
Google Scholar
Gardosi J, Chang A, Kalyan B, et al. Customised antenatal growth charts. Lancet. 1992;339:283–287.
PubMed Web of Science ®Google Scholar
de Jong CL, Gardosi J, Dekker GA, et al. Application of a customised birthweight standard in the assessment of perinatal outcome in a high risk population. BJOG:An International Journal of O&G. 1998;105:531–535.
Web of Science ®Google Scholar
Bouroutzoglou M, Malamitsi-Puchner A, Boutsikou M, et al. Biochemical markers of bone resorption are present in human milk: implications for maternal and neonatal bone metabolism. Acta Paediatr. 2014;103:1264–1269.
PubMed Web of Science ®Google Scholar
Khosla S. Minireview: the OPG/RANKL/RANK system. Endocrinology. 2001;142:5050–5055.
PubMed Web of Science ®Google Scholar
Xu XJ, Shen L, Yang YP, et al. Serum β-catenin levels associated with the ratio of RANKL/OPG in patients with postmenopausal osteoporosis. Int J Endocrinol. 2013;2013:1.
Google Scholar
Colditz J, Thiele S, Baschant U, et al. Postnatal skeletal deletion of Dickkopf-1 increases bone formation and bone volume in male and female mice, despite increased sclerostin expression. J Bone Miner Res. 2018;33:1698–1707.
PubMed Web of Science ®Google Scholar
Fata JE, Kong YY, Li J, et al. The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development. Cell. 2000;103:41–50.
PubMed Web of Science ®Google Scholar
Kovacs CS. Calcium and bone metabolism during pregnancy and lactation. J Mammary Gland Biol Neoplasia. 2005;10:105–118.
PubMed Web of Science ®Google Scholar
Mödder UI, Hoey KA, Amin S, et al. Relation of age, gender, and bone mass to circulating sclerostin levels in women and men. J Bone Miner Res. 2011;26:373–379.
PubMed Web of Science ®Google Scholar
Amrein K, Amrein S, Drexler C, et al. Sclerostin and its association with physical activity, age, gender, body composition, and bone mineral content in healthy adults. J Clin Endocrinol Metab. 2012;97:148–154.
PubMed Web of Science ®Google Scholar
Kalem MN, Kalem Z, Akgun N, et al. The relationship between postmenopausal women’s sclerostin levels and their bone density, age, body mass index, hormonal status, and smoking and consumption of coffee and dairy products. Arch Gynecol Obstet. 2017;295:785–793.
PubMed Web of Science ®Google Scholar
Kundakci Gelir G, Sengul S, Nergizoglu G, et al. Is sclerostin level associated with cardiovascular diseases in hemodialysis patients? Blood Purif. 2018;46:118–125.
PubMed Web of Science ®Google Scholar
García-Martín A, Rozas-Moreno P, Reyes-García R, et al. Circulating levels of sclerostin are increased in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2012;97:234–241.
PubMed Web of Science ®Google Scholar
Briana DD, Boutsikou M, Marmarinos A, et al. Perinatal sclerostin concentrations in abnormal fetal growth: the impact of gestational diabetes. J Matern Fetal Neonatal Med. 2018;1–5.
PubMed Web of Science ®Google Scholar
Briana DD, Gourgiotis D, Georgiadis A, et al. Intrauterine growth restriction may not suppress bone formation at term, as indicated by circulating concentrations of undercarboxylated osteocalcin and Dickkopf-1. Metabolism. 2012;61:335–340.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Inhibitors of osteoblastogenesis in early human milk and maternal serum: evidence for protective properties of mother’s milk on bone

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Inhibitors of osteoblastogenesis in early human milk and maternal serum: evidence for protective properties of mother’s milk on bone

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date